|
ZDHHC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.792400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.004400E-01 |
| Normal-vs-Stage2 |
2.844200E-01 |
| Normal-vs-Stage3 |
5.824100E-02 |
| Normal-vs-Stage4 |
3.942600E-01 |
| Stage1-vs-Stage2 |
4.226400E-01 |
| Stage1-vs-Stage3 |
6.218200E-02 |
| Stage1-vs-Stage4 |
6.051000E-01 |
| Stage2-vs-Stage3 |
6.101200E-01 |
| Stage2-vs-Stage4 |
8.317400E-01 |
| Stage3-vs-Stage4 |
4.299400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.062600E-01 |
| Normal-vs-AfricanAmerican |
4.677800E-01 |
| Normal-vs-Asian |
4.459800E-01 |
| Caucasian-vs-AfricanAmerican |
8.443000E-01 |
| Caucasian-vs-Asian |
7.806400E-01 |
| AfricanAmerican-vs-Asian |
7.025400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.593800E-02 |
| Normal-vs-Female |
4.064400E-01 |
| Male-vs-Female |
3.65940000000009E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.301700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.185600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.090640E-01 |
| Normal-vs-Age(81-100Yrs) |
5.606000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.383600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.930600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.628200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.784100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.729200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.016000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.392000E-01 |
| Normal-vs-Grade 2 |
5.288600E-01 |
| Normal-vs-Grade 3 |
1.198200E-01 |
| Normal-vs-Grade 4 |
1.838170E-01 |
| Grade 1-vs-Grade 2 |
1.481000E-01 |
| Grade 1-vs-Grade 3 |
9.280000E-02 |
| Grade 1-vs-Grade 4 |
1.024570E-01 |
| Grade 2-vs-Grade 3 |
2.252200E-01 |
| Grade 2-vs-Grade 4 |
2.961800E-01 |
| Grade 3-vs-Grade 4 |
8.944800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.884400E-01 |
| Normal-vs-ccB subtype |
8.416100E-02 |
| ccA subtype-vs-ccB subtype |
7.517400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.823000E-01 |
| Normal-vs-N1 |
8.197400E-01 |
| N0-vs-N1 |
5.123600E-01 |
|
|
